Phytother Res June 2014 PMID 24318647

Suppression of lipopolysaccharide-stimulated cytokine/chemokine production in skin cells by sandalwood oils and purified α-santalol and β-santalol.

M Sharma, C Levenson, R H Bell, S A Anderson, J B Hudson, C C Collins, M E Cox

Mentions

26
Peak: 1 in Dec 2021
across 4 sources since Dec 2021

Extended reach

14,429
potential audience

Total likes

625

Video views

14,363

Mentions per month

Dec 2021 – Oct 2023

Where it's discussed

  • Facebook21 posts
  • YouTube2 videos
  • News2 articles
  • X / Twitter1 posts

AI synopsis

What people are saying

Discussions reflect a balanced view, with some posts emphasizing how sandalwood oils could be used in anti-inflammatory products, such as creams or supplements, indicating recognition of the article's potential influence. Words like 'rationale for use' and 'anti-inflammatory effects' suggest a focus on practical applications and emerging interest but lack extensive debate or technical analysis.

AgreementModerate agreement

Most discussions acknowledge the potential anti-inflammatory benefits of sandalwood oils as suggested by the publication.

InterestNeutral interest

The conversations show moderate interest, with some posts highlighting practical applications but not delving deeply into scientific details.

EngagementModerate engagement

Several posts refer to how this research could influence product development, indicating a moderate level of engagement.

ImpactModerate impact

The overall tone suggests that the findings could have a meaningful impact on industries like skincare and pharmaceuticals.

Abstract in brief

  • Sandalwood oils (SO), including purified santalol, exhibit anti-inflammatory effects by suppressing cytokine and chemokine production in skin cells stimulated with lipopolysaccharides, similar to the action of ibuprofen.
  • The study found that sandalwood oils from Western Australian and East Indian sources reduced the release of 26 inflammatory mediators, with higher santalol levels in East Indian SO correlating with increased activity.
  • The anti-inflammatory mechanism appears to involve inhibition of cyclooxygenase pathways, leading to decreased production of prostaglandin E2 and thromboxane B2, supporting the therapeutic potential of SOs in products targeting inflammation.

Top posts

Most liked on X and Bluesky
Tim Hodge
@Timedx1 · X

a rationale for use in products requiring antiinflammatory effects. https://t.co/L2VZtepqir

Dec 12, 2021 · 67 followers View post →

All mentions

Tim Hodge
@Timedx1 · X

a rationale for use in products requiring antiinflammatory effects. https://t.co/L2VZtepqir

Dec 12, 2021 · 67 followers View post →